BR100 Decreased By (-0.54%)
BR30 Decreased By (-0.84%)
KSE100 Decreased By (-0.48%)
KSE30 Decreased By (-0.44%)
AGHA 6.62 Decreased By ▼ -0.05 (-0.75%)
BECO 4.35 No Change ▼ 0.00 (0%)
BML 55.20 Decreased By ▼ -0.97 (-1.73%)
BOP 29.98 Decreased By ▼ -0.14 (-0.46%)
CNERGY 12.74 Decreased By ▼ -0.24 (-1.85%)
CSIL 5.19 Decreased By ▼ -0.12 (-2.26%)
FCCL 51.01 Decreased By ▼ -0.64 (-1.24%)
FFL 14.44 Decreased By ▼ -0.05 (-0.35%)
FNEL 1.20 Decreased By ▼ -0.01 (-0.83%)
KEL 6.04 Decreased By ▼ -0.02 (-0.33%)
KOSM 5.55 Decreased By ▼ -0.29 (-4.97%)
LOTCHEM 26.05 Decreased By ▼ -0.12 (-0.46%)
MLCF 89.42 Decreased By ▼ -1.81 (-1.98%)
NBP 162.50 Decreased By ▼ -1.69 (-1.03%)
NCPL 52.50 Decreased By ▼ -0.68 (-1.28%)
NPL 58.22 Decreased By ▼ -0.90 (-1.52%)
OGDC 313.00 Decreased By ▼ -0.39 (-0.12%)
PACE 9.70 Decreased By ▼ -0.07 (-0.72%)
PAEL 34.95 Decreased By ▼ -0.29 (-0.82%)
PIBTL 14.24 Decreased By ▼ -0.47 (-3.2%)
PPL 219.20 Decreased By ▼ -2.16 (-0.98%)
PRL 91.30 Increased By ▲ 0.08 (0.09%)
PTC 58.70 Decreased By ▼ -0.49 (-0.83%)
SSGC 23.32 Increased By ▲ 0.02 (0.09%)
TBL 8.62 Decreased By ▼ -0.13 (-1.49%)
TELE 7.46 Decreased By ▼ -0.15 (-1.97%)
TPL 21.30 Decreased By ▼ -0.73 (-3.31%)
TPLP 12.13 Decreased By ▼ -0.43 (-3.42%)
TREET 21.60 Decreased By ▼ -0.13 (-0.6%)
TRG 55.24 Decreased By ▼ -0.55 (-0.99%)

KARACHI: Ali & Associates, in collaboration with the US Consulate General Karachi, successfully hosted a high-level roundtable on Biotechnology and Intellectual Property (IP) Law at its Karachi office. The event brought together leading representatives from government bodies, academia, pharmaceutical and biotech industries, and international organizations for a groundbreaking discussion on the future of biotechnology and intellectual property in Pakistan.

The roundtable explored the critical nexus between scientific research, healthcare innovation, and intellectual property frameworks, highlighting how stronger IP systems can accelerate biotech breakthroughs, foster research commercialization, and enhance access to advanced therapies for patients.

Prominent participants included representatives from the Intellectual Property Organization of Pakistan (IPO-Pakistan), the Drug Regulatory Authority of Pakistan (DRAP), the Pakistan Pharmaceutical Manufacturers Association (PPMA), leading academic and research institutions, as well as representatives from the pharmaceutical, biotechnology, and agricultural sectors.

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.